Global Clinical Laboratory Service Market Size Study & Forecast, By Test Type (Genetic Testing, Clinical Chemistry, Medical Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, Drug of Abuse Testing. Other Esoteric Tests) By Ser

Global Clinical Laboratory Service Market Size Study & Forecast, By Test Type (Genetic Testing, Clinical Chemistry, Medical Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, Drug of Abuse Testing. Other Esoteric Tests) By Service Provider (Hospital-based Laboratories, Stand-alone Laboratories, Clinic-based Laboratories), By Application (Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services, Drug Discovery & Development Related Services, Other Clinical Laboratory Services) and Regional Analysis, 2023-2030

Global Clinical Laboratory Service Market is valued at approximately USD 225.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Clinical laboratory services encompass a broad range of diagnostic and testing procedures performed on clinical specimens, such as blood, urine, tissue samples, and other bodily fluids, to aid in the diagnosis, monitoring, and treatment of diseases and medical conditions. These services are provided by clinical laboratories, which may be part of hospitals, healthcare facilities, independent diagnostic laboratories, or reference laboratories. Clinical laboratory testing plays a critical role in healthcare by providing healthcare providers with essential information for patient care, including identifying the presence of pathogens, measuring levels of biomarkers or analytes, assessing organ function, monitoring treatment effectiveness, and detecting genetic abnormalities. The Clinical Laboratory Service market is expanding because of factors such as the increasing prevalence of chronic and infectious diseases, growing emphasis on personalized medicine, and rising healthcare expenditure.

The market is driven by a surge in chronic and infectious diseases and an escalating need for precise and early disease detection techniques. The global burden of infectious diseases and chronic conditions is on the rise, amplifying demand for clinical diagnostic tests as a reliable means to identify and delineate various biomarkers associated with chronic ailments and microbial pathogens. This demand intensifies in tandem with the mounting prevalence of diseases like cancer and tuberculosis (TB). For example, recent data from the World Health Organization (WHO) reveals a staggering global tuberculosis prevalence, with approximately 10 million individuals affected as of 2021, encompassing 5.6 million men, 3.3 million women, and 1.1 million children. The persistent high prevalence of such diseases is anticipated to drive an upsurge in demand for clinical services, thereby fostering market growth. Moreover, the escalating burden of cancer is projected to further propel the need for clinical diagnostics. As evidenced by the Globocan Statistics 2020, there were 19.3 million new cancer cases recorded worldwide, encompassing both genders, with the incidence of cancer rapidly escalating on a global scale. Projections indicate that the number of new cancer cases across genders will soar to an estimated 30.2 million by the year 2040. In addition, rising technological advancement in clinical testing and a growing number of geographical expansion strategies are creating new opportunities for market growth. However, stringent regulatory requirements and standards and the growing popularity of point-of-care testing (POCT) devices stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Laboratory Service Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing high prevalence of chronic diseases, a well-established healthcare infrastructure, and a growing geriatric population. The region benefits from a robust healthcare system and a comprehensive reimbursement framework for clinical laboratory services. Additionally, the attractiveness of the business has led to the entry of new players into the market. For example, in February 2023, Dutch biotech company Detact Diagnostics announced the establishment of a new laboratory at Keene State College (U.S.) under a 2-year rental contract. Furthermore, Asia Pacific is expected to grow at the fastest rate during the forecast period, primarily attributed to the rise in scientific research, addressing unmet medical needs, economic expansion, and enhancements in healthcare infrastructure and regulatory frameworks. Moreover, increasing public awareness and the accessibility of advanced medical treatments are expected to further drive growth in the region. The significance of clinical laboratory services has been magnified during the COVID-19 pandemic, given the heightened demand for testing. Major industry players are strategically partnering to introduce innovative laboratory testing services to meet evolving market needs in the Asia Pacific region.

Major market players included in this report are:
Laboratory Corporation of America Holdings (LabCorp)
QIAGEN NV
Eurofins Scientific SE
Quest Diagnostics Incorporated
OPKO Health, Inc.
Siemens Medical Solutions USA, Inc.
NeoGenomics Laboratories
Fresenius Medical Care
ARUP Laboratories
Sonic Healthcare

Recent Developments in the Market:
 In August 2023, Laboratory Corporation of America Holdings (Labcorp) finalized an agreement with Tufts Medicine to acquire Tufts Medicine Outreach Laboratory Business. This acquisition aims to broaden Labcorp's diagnostic testing and laboratory services offerings.
 In February 2023, Dutch biotech company Detact Diagnostics disclosed plans to establish a new laboratory at Keene State College (U.S.) through a two-year rental agreement.

Global Clinical Laboratory Service Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Test Type, Service Provider, Application, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Test Type:
Genetic Testing
Clinical Chemistry
Medical Microbiology Testing
Hematology Testing
Immunology Testing
Cytology Testing
Drug of Abuse Testing
Other Esoteric Tests

By Service Provider:
Hospital-based Laboratories
Stand-alone Laboratories
Clinic-based Laboratories

By Application:
Bioanalytical & Lab Chemistry Services
Toxicology Testing Services
Cell & Gene Therapy Related Services
Preclinical & Clinical Trial Related Services
Drug Discovery & Development Related Services
Other Clinical Laboratory Services

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.